Illumina (ILMN) | Financial Analysis & Statements

Illumina, Inc. | Large-cap | Healthcare

$97.15

-3.62%

Illumina vs Thermo Fisher Illumina vs Danaher Illumina vs Idexx Laboratories Illumina vs Agilent Technologies Illumina vs Iqvia Holdings Illumina vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 4.4B

Gross Profit 2.9B 65.44%

Operating Income 600.0M 13.72%

Net Income -1.2B -27.97%

EPS (Diluted) -$7.69

Balance Sheet Metrics

Total Assets 6.3B

Total Liabilities 3.9B

Shareholders Equity 2.4B

Debt to Equity 1.66

Cash Flow Metrics

Operating Cash Flow -956.0M

Free Cash Flow 709.0M

Revenue & Profitability Trend

Illumina Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	4.4B	4.5B	4.6B	4.5B	3.2B
Cost of Goods Sold	1.5B	1.8B	1.6B	1.4B	1.0B
Gross Profit	2.9B	2.7B	3.0B	3.2B	2.2B
Operating Expenses	2.3B	3.0B	2.6B	3.3B	1.6B
Operating Income	600.0M	-222.0M	354.0M	-123.0M	580.0M
Pre-tax Income	-1.2B	-1.1B	-4.3B	884.0M	856.0M
Income Tax	44.0M	44.0M	68.0M	122.0M	200.0M
Net Income	-1.2B	-1.2B	-4.4B	762.0M	656.0M
EPS (Diluted)	-$7.69	-$7.34	-$28.00	$5.04	$4.45

Income Statement Trend

Illumina Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	2.7B	2.6B	3.6B	2.7B	4.5B
Non-Current Assets	3.6B	7.5B	8.7B	12.5B	3.1B
Total Assets	6.3B	10.1B	12.3B	15.2B	7.6B
Liabilities
Current Liabilities	1.5B	1.6B	2.8B	1.1B	1.2B
Non-Current Liabilities	2.4B	2.8B	2.9B	3.4B	1.6B
Total Liabilities	3.9B	4.4B	5.7B	4.5B	2.9B
Equity
Total Shareholders Equity	2.4B	5.7B	6.6B	10.7B	4.7B

Balance Sheet Composition

Illumina Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-1.2B	-1.2B	-4.4B	762.0M	656.0M
Operating Cash Flow	-956.0M	-537.0M	-4.1B	1.4B	1.3B
Investing Activities
Capital Expenditures	-128.0M	-195.0M	-286.0M	-208.0M	-189.0M
Investing Cash Flow	-178.0M	-230.0M	-411.0M	-1.1B	-686.0M
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	-570.0M	-1.2B	1.0B	-51.0M	-766.0M
Free Cash Flow	709.0M	282.0M	-74.0M	337.0M	891.0M

Cash Flow Trend

Illumina Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -11.90

Forward P/E 20.50

Price to Book 6.08

Price to Sales 3.31

PEG Ratio 20.50

Profitability Ratios

Profit Margin -22.27%

Operating Margin 17.67%

Return on Equity -23.85%

Return on Assets 4.96%

Financial Health

Current Ratio 1.86

Debt to Equity 110.09

Beta 1.33

Per Share Data

EPS (TTM) -$6.08

Book Value per Share $14.89

Revenue per Share $27.28

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
ilmn	14.3B	-11.90	6.08	-23.85%	-22.27%	110.09
Thermo Fisher	152.5B	23.69	3.09	13.70%	15.19%	69.23
Danaher	140.5B	37.98	2.76	7.22%	15.81%	34.56
Idexx Laboratories	42.1B	48.33	29.21	59.33%	22.76%	73.16
Agilent Technologies	33.0B	28.60	5.37	18.88%	17.59%	60.04
Iqvia Holdings	27.4B	21.64	4.61	21.64%	8.61%	242.91

Financial data is updated regularly. All figures are in the company's reporting currency.